MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 578.29 millions during the quarter ended September 2023. The figure stood at Rs. 605.26 millions during the year-ago period.The Company's Net profit for the September 2023 quarter have declined marginally to Rs. 74.72  millions as against Rs. 104.12 millions reported during the corresponding quarter ended.The company reported a degrowth in operating Profit to 106.39 millions from 140.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 578.29 605.26 -4.46 1179.82 1211.23 -2.59 2367.14 2175.84 8.79
Other Income 22.74 11.21 102.85 42.71 14.35 197.63 57.34 34.27 67.32
PBIDT 106.39 140.23 -24.13 212.73 215.15 -1.12 398.85 284.55 40.17
Interest 2.21 0.26 750.00 3.71 0.40 827.50 4.13 2.85 44.91
PBDT 104.18 139.97 -25.57 209.02 180.16 16.02 360.13 281.70 27.84
Depreciation 4.55 2.04 123.04 8.48 3.97 113.60 12.05 15.26 -21.04
PBT 99.63 137.93 -27.77 200.54 176.19 13.82 348.08 266.44 30.64
TAX 24.91 33.81 -26.32 51.03 42.86 19.06 80.87 77.87 3.85
Deferred Tax -0.92 1.43 -164.34 -0.81 -7.36 -88.99 4.56 3.84 18.75
PAT 74.72 104.12 -28.24 149.51 133.33 12.14 267.21 188.57 41.70
Equity 130.99 130.99 0.00 130.99 130.99 0.00 130.99 130.99 0.00
PBIDTM(%) 18.40 23.17 -20.59 18.03 17.76 1.51 16.85 13.08 28.84

Jagsonpal Pharma Share Price

226.80 -2.75 (-1.20%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: